TR201108946A2 - Dondurularak kurutulmuş atp, vitamin b kompleksi preparatı ve enjeksiyonu. - Google Patents

Dondurularak kurutulmuş atp, vitamin b kompleksi preparatı ve enjeksiyonu.

Info

Publication number
TR201108946A2
TR201108946A2 TR2011/08946A TR201108946A TR201108946A2 TR 201108946 A2 TR201108946 A2 TR 201108946A2 TR 2011/08946 A TR2011/08946 A TR 2011/08946A TR 201108946 A TR201108946 A TR 201108946A TR 201108946 A2 TR201108946 A2 TR 201108946A2
Authority
TR
Turkey
Prior art keywords
vitamin
freeze
injection
dried
atp
Prior art date
Application number
TR2011/08946A
Other languages
English (en)
Inventor
Tahi̇yeu Raushan
Original Assignee
World Medicine İlaç Sanayi̇ Ve Ti̇caret Li̇mi̇ted Şi̇rketi̇
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by World Medicine İlaç Sanayi̇ Ve Ti̇caret Li̇mi̇ted Şi̇rketi̇ filed Critical World Medicine İlaç Sanayi̇ Ve Ti̇caret Li̇mi̇ted Şi̇rketi̇
Priority to TR2011/08946A priority Critical patent/TR201108946A2/tr
Publication of TR201108946A2 publication Critical patent/TR201108946A2/tr
Priority to EA201270717A priority patent/EA030298B1/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Teknik alan;mevcut buluş farmasötik teknoloji alanı ile ilgilidir ve dondurularak kurutulmuş adenozin trifosfat ile vitamin b kompleksi preparatlarını ve adenozin trifosfat ile vitamin b kompleksi enjeksiyonunu tarif etmektedir. Ayrıca, bu buluş dondurularak kurutulmuş adenozin trifosfat ile vitamin b kompleksi üretimi ve adenozin trifosfat ile vitamin b kompleksi enjeksiyonu için bir üretimle ilgilidir.
TR2011/08946A 2011-09-12 2011-09-12 Dondurularak kurutulmuş atp, vitamin b kompleksi preparatı ve enjeksiyonu. TR201108946A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2011/08946A TR201108946A2 (tr) 2011-09-12 2011-09-12 Dondurularak kurutulmuş atp, vitamin b kompleksi preparatı ve enjeksiyonu.
EA201270717A EA030298B1 (ru) 2011-09-12 2012-09-12 Лиофилизированный препарат атф и комплекса витаминов группы в и атф и комплекс витаминов группы в виде инъекций

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2011/08946A TR201108946A2 (tr) 2011-09-12 2011-09-12 Dondurularak kurutulmuş atp, vitamin b kompleksi preparatı ve enjeksiyonu.

Publications (1)

Publication Number Publication Date
TR201108946A2 true TR201108946A2 (tr) 2012-04-24

Family

ID=47680206

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/08946A TR201108946A2 (tr) 2011-09-12 2011-09-12 Dondurularak kurutulmuş atp, vitamin b kompleksi preparatı ve enjeksiyonu.

Country Status (2)

Country Link
EA (1) EA030298B1 (tr)
TR (1) TR201108946A2 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107890460B (zh) * 2017-12-21 2020-07-07 广州白云山天心制药股份有限公司 一种三磷酸腺苷二钠组合物粉针剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2080856C1 (ru) * 1993-02-10 1997-06-10 Научно-производственное объединение "Иммунопрепарат" Способ получения инъекционной формы препарата атф
US7399489B2 (en) * 1999-01-14 2008-07-15 Amylin Pharmaceuticals, Inc. Exendin analog formulations
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
RU2423130C2 (ru) * 2006-02-03 2011-07-10 Актелион Уан Са Композиция, содержащая эпопростенол, и способ ее получения
CN101785780B (zh) * 2010-04-07 2014-05-21 深圳市资福药业有限公司 一种腺苷钴胺与腺苷组合物的制剂及其制备方法

Also Published As

Publication number Publication date
EA030298B1 (ru) 2018-07-31
EA201270717A2 (ru) 2013-03-29
EA201270717A3 (ru) 2013-07-30

Similar Documents

Publication Publication Date Title
DOP2021000095A (es) Composiciones y métodos para modular la expresión de ttr
CR20150263A (es) Compuestos de pirrolopirimidina como inhibidores de quinasas
EA201690780A1 (ru) Пегилированные лекарственные средства-линкеры для улучшенной фармакокинетики конъюгатов лиганд-лекарственное средство
BR112016005957A2 (pt) detecção de alvo multiaptâmero
BR112015000615A8 (pt) Purinas macrocíclicas para o tratamento de infecções virais e composição farmacêutica que as compreende
GT201400142A (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
BR112012018021A2 (pt) antídotos anticoagulantes.
BR112015009059A2 (pt) sistema de produção de empuxo não canalizado
MY167620A (en) Smoking article including dual heat-conducting elements
BR112016008576A2 (pt) Formulações aquosas estáveis de anticorpos e forma farmacêutica de dosagem unitária
EA201590161A1 (ru) Составы этанерцепта, отличающиеся заметным уменьшением содержания частиц довидимого диапазона
ECSP14026138A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
ECSP14008757A (es) Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
BR112015031027A2 (pt) Uso de um composto, método in vitro, composição farmacêutica e forma de dosagem única
BR112015012919A2 (pt) novos derivados de piridina
AR091465A1 (es) Una composicion farmaceutica que contiene acido nicotinico y/o nicotinamida y/o triptofano para influenciar positivamente la microbiota intestinal
BR122019021714B8 (pt) preparação compreendendo vitamina b12 e butanol e butafosfano, e seu uso
CR20160072A (es) Compuestos y composiciones como inhibidores de la mek
UY34406A (es) Compuestos y métodos para mejorar la respuesta inmune innata
BR112015023523B8 (pt) Composições farmacêuticas e recipiente de forma de dosagem única
BR112015009603A2 (pt) novos derivados de pirazina
IN2015DN00924A (tr)
TR201905787T4 (tr) Liyofilize TAT-NR2B9C formülasyonu.
UY33994A (es) Molécula de anticuerpo de dabigatran y derivados como antídotos anticoagulantes
CR20120494S (es) Empaque blister para producto